Yildirim, Hasan Cagri; Mutlu, Emel; Chalabiyev, Elvin; Ozen, Mirac; Keskinkilic, Merve; On, Sercan; Celebi, Abdussamet; Dursun, Bengu; Acar, Omer; Kahraman, Seda; Aykan, Musa Baris; Kaman, Omur
(CHURCHILL LIVINGSTONE, 2022)
Background: Since breast cancer is less common in men than in women, data on the use of new therapeutic agents, including cyclin-dependent kinase 4-6 (CDK 4-6) inhibitors, are limited in patients with metastatic hormone ...